logo
#

Latest news with #LamResearch

UBS Raises PT on Lam Research Corporation (LRCX) from $95 to $120
UBS Raises PT on Lam Research Corporation (LRCX) from $95 to $120

Yahoo

time2 days ago

  • Business
  • Yahoo

UBS Raises PT on Lam Research Corporation (LRCX) from $95 to $120

Lam Research Corporation (NASDAQ:LRCX) secures a place on our list of the . the-main-processor-3334336_1280 On July 21, 2025, UBS increased its price target on Lam Research Corporation (NASDAQ:LRCX) from $95 to $120, maintaining a 'Buy' rating. This revision comes amid growing optimism for the company's Q4 performance. The analyst attributed the optimism to ongoing NAND equipment upgrades by Samsung, potential upside from TSMC, and strong demand out of China. Furthermore, the analyst expressed a positive outlook on the wafer fabrication equipment (WFE) market environment and Lam Research Corporation (NASDAQ:LRCX)'s positioning. Therefore, with investments ramping up globally in the semiconductor market, LRCX seems to be well-positioned to capitalize on the chipmaking demand surge. Lam Research Corporation (NASDAQ:LRCX), serving major foundries and integrated device manufacturers worldwide, manufactures advanced semiconductor processing equipment for chip production. It is one of the best ESG stocks. While we acknowledge the potential of LRCX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 14 Cheap Transportation Stocks to Buy According to Analysts and Top 10 AI Infrastructure Stocks to Buy Now. Disclosure: None. Sign in to access your portfolio

Jim Cramer Says: 'Don't Be in a Hurry to Buy Lam Research'
Jim Cramer Says: 'Don't Be in a Hurry to Buy Lam Research'

Yahoo

time2 days ago

  • Business
  • Yahoo

Jim Cramer Says: 'Don't Be in a Hurry to Buy Lam Research'

Lam Research Corporation (NASDAQ:LRCX) is one of the stocks that Jim Cramer recently commented on. During the episode, Cramer recommended against buying the company stock, as he remarked: 'It would be best to accept that the food and drugs can have a couple of days in the sun, can't they? The old leaders pulled back a little, can't they? Don't be in a hurry to buy Lam Research or Applied Materials or KLA… not after we had Texas Instruments on tonight, and I wouldn't step in front of the falling knives that represent any of the meme stocks…' Photo by AlphaTradeZone Lam Research (NASDAQ:LRCX) develops equipment used in semiconductor manufacturing and provides advanced systems for deposition, etching, and cleaning processes important to integrated circuit production. During a March episode, Cramer said that he 'would own the stock.' He commented 'I like Lam very much. Right now, it's in the crosshairs of a lot of different geopolitical concerns. It's one of those stocks that I think is deeply involved with the negativity right now. It's a shame because Tim Archer's not a negative guy and they are a fabulous company. I would own the stock.' While we acknowledge the potential of LRCX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Jim Cramer Says: 'Don't Be in a Hurry to Buy Lam Research'
Jim Cramer Says: 'Don't Be in a Hurry to Buy Lam Research'

Yahoo

time3 days ago

  • Business
  • Yahoo

Jim Cramer Says: 'Don't Be in a Hurry to Buy Lam Research'

Lam Research Corporation (NASDAQ:LRCX) is one of the stocks that Jim Cramer recently commented on. During the episode, Cramer recommended against buying the company stock, as he remarked: 'It would be best to accept that the food and drugs can have a couple of days in the sun, can't they? The old leaders pulled back a little, can't they? Don't be in a hurry to buy Lam Research or Applied Materials or KLA… not after we had Texas Instruments on tonight, and I wouldn't step in front of the falling knives that represent any of the meme stocks…' Photo by AlphaTradeZone Lam Research (NASDAQ:LRCX) develops equipment used in semiconductor manufacturing and provides advanced systems for deposition, etching, and cleaning processes important to integrated circuit production. During a March episode, Cramer said that he 'would own the stock.' He commented 'I like Lam very much. Right now, it's in the crosshairs of a lot of different geopolitical concerns. It's one of those stocks that I think is deeply involved with the negativity right now. It's a shame because Tim Archer's not a negative guy and they are a fabulous company. I would own the stock.' While we acknowledge the potential of LRCX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

These stocks reporting next week usually top analyst estimates and gain afterward
These stocks reporting next week usually top analyst estimates and gain afterward

CNBC

time4 days ago

  • Business
  • CNBC

These stocks reporting next week usually top analyst estimates and gain afterward

Looking at history, several stocks scheduled to soon report earnings could beat estimates and outperform the market the day after. Second-quarter earnings have impressed analysts so far, with the majority of S & P 500 companies having posted positive earnings per share and revenue surprises. Several leading stocks are on deck to post results next week, including Microsoft , Mastercard , Lam Research , Spotify and UnitedHealth Group . Strong earnings have helped power the broad market to new all-time highs this month, with the S & P 500 on Thursday scoring its 12th all-time high close of the year. To find potential winners, CNBC Pro screened data from Bespoke Investment Group for stocks reporting next week that have a track record of exceeding analysts' consensus earnings forecasts and then gaining the next trading day. The companies below are among a handful of names soon to report that have beaten earnings per share estimates 80% of the time and, on average, gain at least 1% or more during the session after posting their latest financials. Take a look: Mastercard reports earnings on Thursday. The credit card processor has historically beaten analysts' earnings estimates 93% of the time, and on average has gained 1.7% following the earnings report. Shares of Mastercard are up roughly 7% this year. The stock is positively viewed by the Street. Of 40 analysts covering Mastercard, 30 have a strong buy or buy rating on the shares. Deutsche Bank analyst Nate Svensson is bullish on Mastercard and has a $650 price target on shares, suggesting more than 15% potential upside based on Thursday's close. In a late June note to clients, he named Mastercard as one of several "high quality compounders" among payments and processing providers. Booking Holdings also routinely beats the Street, with a history of topping earnings expectations 90% of the time and seeing an average post-earnings gain of 2%. The travel company is set to report results next Tuesday. Shares of the Priceline and OpenTable parent are up more than 13% year to date, making Booking's valuation appear "fairly full and several turns higher than the long-term average," according to a recent note from Barclays analyst Trevor Young. Young said last week that "this full valuation combined with a generally in-line 2Q print/3Q guide might keep a lid on shares near term, but we again highlight BKNG as the best quality name to own within the group on a relative basis." Other stocks that matched the search criteria for potential outperformers include semiconductor companies Lam Research and Monolithic Power Systems , which have a track record of rising 1.3% and 2.5%, respectively, on the next trading day after earnings.

LRCX Likely to Beat Q4 Earnings Estimates: How to Play the Stock?
LRCX Likely to Beat Q4 Earnings Estimates: How to Play the Stock?

Globe and Mail

time5 days ago

  • Business
  • Globe and Mail

LRCX Likely to Beat Q4 Earnings Estimates: How to Play the Stock?

Lam Research Corporation LRCX is scheduled to release its fourth-quarter fiscal 2025 results on July 30. The company expects revenues of $5 billion (+/- $300 million) for the fourth quarter. The Zacks Consensus Estimate is pegged at $4.99 billion, indicating 28.9% growth from the figure reported in the year-ago quarter. Lam Research expects earnings of $1.20 (+/- $0.10) for the fourth quarter. The consensus mark for fourth-quarter earnings has remained unchanged at $1.20 per share over the past 60 days, implying a 48.2% year-over-year increase. Lam Research has an impressive earnings surprise history. In the last reported quarter, LRCX delivered an earnings surprise of 4.6%. The company's earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 6.1%. Lam Research Corporation Price and EPS Surprise Lam Research Corporation price-eps-surprise | Lam Research Corporation Quote Earnings Whispers for LRCX Our proven model predicts an earnings beat for Lam Research this earnings season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is the case here. Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate ($1.23) and the Zacks Consensus Estimate ($1.20), is +2.71%. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter. Zacks Rank: LRCX carries a Zacks Rank #2. You can see the complete list of today's Zacks #1 Rank stocks here. Factors Likely to Influence LRCX's Q4 Results Lam Research has been riding on the wave of a strong rebound in the semiconductor industry, driven by the surging demand for memory and advanced AI applications. The rise in spending on AI and machine learning, particularly with the growing influence of Generative AI, is likely to have provided a significant boost to the company's performance in the fiscal fourth quarter. The increasing need for advanced AI-centric chips has become a key growth catalyst. Heightened dynamic random access memory (DRAM) spending, especially in response to demand for high-bandwidth memory, is likely to have played in Lam Research's favor. The company's momentum in 3D DRAM and advanced packaging technologies is also expected to have added to its strong performance. At the same time, ongoing technological advancements are pushing NAND spending higher, which is likely to contribute to LRCX's quarterly results. Lam Research's focus on expanding semiconductor fabrication capabilities, along with its heavy investment in research and development, positions it well in a competitive landscape. Its innovation through Semiverse solutions, particularly in high-aspect-ratio memory hole etch for NAND, is likely to have fueled this progress. LRCX's strategic investments in cutting-edge technologies are likely to have bolstered its performance in the foundry and logic segment, while the increasing adoption of 3D architectures is expected to have supported growth in its etch and deposition services. The company's robust suite of tools, which enable foundry logic inflections, is likely to have secured strong customer traction. With the accelerating deployment of 5G and the Internet of Things (IoT), Lam Research's semiconductor and memory solutions remain in high demand, reinforcing its market position in the fiscal fourth quarter. All these factors are likely to have driven growth in system revenues. The Zacks Consensus Estimate forecasts fiscal fourth-quarter system revenues at $3.22 billion, implying year-over-year growth of 48.5%, underscoring Lam Research's continued strength in the evolving tech landscape. The consensus mark for the Customer Support segment's fourth-quarter revenues is pegged at $1.76 billion, indicating a year-over-year increase of 3.4%. LRCX Stock Price Performance & Valuation Lam Research shares have gained 9.8% over the past year, underperforming the Zacks Electronics – Semiconductors industry, which has risen 39.5%. The stock has also underperformed major semiconductor players, including Broadcom AVGO, NVIDIA NVDA and Marvell Technology MRVL. Shares of Broadcom, NVIDIA and Marvell Technology have soared 90%, 52.1% and 14.5%, respectively. One-Year Price Return Performance Image Source: Zacks Investment Research Let us look at the value Lam Research offers investors at current levels. Currently, LRCX is trading at a discount, with a forward 12-month P/E of 24.1X compared with the industry's 33.76X. Compared with semiconductor giants, the stock trades at lower multiples than Broadcom and NVIDIA, while at a higher multiple than Marvell Technology. At present, Broadcom, NVIDIA and Marvell Technology have forward 12-month P/E multiples of 36.23, 34.76 and 23.17, respectively. Investment Thesis for Lam Research Stock Lam Research is benefiting from powerful shifts in semiconductor demand, particularly around AI and data center chips. These advanced chips require complex manufacturing, and Lam provides the essential tools, like deposition and etching systems, needed to build them. In 2024 alone, Lam Research shipped more than $1 billion worth of products tied to next-gen chip technologies and packaging. The figure is expected to triple in 2025. LRCX's equipment is especially critical as the industry moves toward innovations like backside power delivery and dry-resist processing. Lam Research's steady investments in research & development and new products are paying off. Its Cryo 3.0 technology has set new standards in the industry, and the Aether dry-resist system is being adopted, especially for high-bandwidth DRAM. Expanding its manufacturing operations in Asia has also helped the company lower costs and improve margins. In the third quarter of fiscal 2025, Lam Research's non-GAAP operating margin rose to 32.8%, up 210 basis points from last year, which is impressive, considering the tough conditions in the semiconductor market. Conclusion: Buy Lam Research for Now Lam Research's reasonable valuation, strong financials and clear focus on AI-related growth make it a good investment choice right now. Its market position in AI and data center chipmaking, combined with ongoing innovation, should keep driving long-term gains. 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NVIDIA Corporation (NVDA): Free Stock Analysis Report Lam Research Corporation (LRCX): Free Stock Analysis Report Marvell Technology, Inc. (MRVL): Free Stock Analysis Report Broadcom Inc. (AVGO): Free Stock Analysis Report

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store